Global Pharmacovigilance Market Size, Status and Forecast 2020-2026

世界のファーマコビジランス市場2026:インサイト・予測

◆タイトル:Global Pharmacovigilance Market Size, Status and Forecast 2020-2026
◆商品コード:QYR20NV04258
◆調査・発行会社:QYResearch
◆発行日:2020年11月
◆ページ数:93
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥448,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥672,750見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートはファーマコビジランスの世界市場について調査・分析した資料です。種類別(化学療法、契約アウトソーシング)の市場規模、用途別(製薬およびバイオテクノロジー企業、委託研究機関(CRO)、ビジネスプロセスアウトソーシング(BPO)企業、その他)の市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)の市場規模データ、主な企業情報と企業別市場シェア等が記載されています。
・調査範囲
・エグゼクティブサマリー
・企業別ファーマコビジランスの競争状況、市場シェア
・世界のファーマコビジランス市場:種類別市場規模 2015年-2020年(化学療法、契約アウトソーシング)
・世界のファーマコビジランス市場:種類別市場規模予測 2021年-2026年(化学療法、契約アウトソーシング)
・世界のファーマコビジランス市場:用途別市場規模 2015年-2020年(製薬およびバイオテクノロジー企業、委託研究機関(CRO)、ビジネスプロセスアウトソーシング(BPO)企業、その他)
・世界のファーマコビジランス市場:用途別市場規模予測 2021年-2026年(製薬およびバイオテクノロジー企業、委託研究機関(CRO)、ビジネスプロセスアウトソーシング(BPO)企業、その他)
・北米のファーマコビジランス市場分析:米国、カナダ
・ヨーロッパのファーマコビジランス市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのファーマコビジランス市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のファーマコビジランス市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのファーマコビジランス市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Eli Lilly and Company、ICON plc、Elsevier、Chiltern、Atlantic Research Group、Mapi Group、Accenture Plc.、Clinquest Group B.V.、GSK、PRA Health Sciences, Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Pharmacovigilance Market
The global Pharmacovigilance market size is projected to reach US$ 4521.3 million by 2026, from US$ 4159.2 million in 2020, at a CAGR of 8.1%% during 2021-2026.

Global Pharmacovigilance Scope and Market Size
Pharmacovigilance market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacovigilance market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Eli Lilly and Company
ICON plc
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Accenture Plc.
Clinquest Group B.V.
GSK
PRA Health Sciences, Inc.

Market segment by Type, the product can be split into
Chemotherapy
Contract Outsourcing
Market segment by Application, split into
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Other Pharmacovigilance Service Providers

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pharmacovigilance Revenue
1.4 Market by Type
1.4.1 Global Pharmacovigilance Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Contract Outsourcing
1.5 Market by Application
1.5.1 Global Pharmacovigilance Market Share by Application: 2020 VS 2026
1.5.2 Pharma and Biotech Companies
1.5.3 Contract Research Organizations (CROs)
1.5.4 Business Process Outsourcing (BPO) Firms
1.5.5 Other Pharmacovigilance Service Providers
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Pharmacovigilance Market Perspective (2015-2026)
2.2 Global Pharmacovigilance Growth Trends by Regions
2.2.1 Pharmacovigilance Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pharmacovigilance Historic Market Share by Regions (2015-2020)
2.2.3 Pharmacovigilance Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pharmacovigilance Market Growth Strategy
2.3.6 Primary Interviews with Key Pharmacovigilance Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance Players by Market Size
3.1.1 Global Top Pharmacovigilance Players by Revenue (2015-2020)
3.1.2 Global Pharmacovigilance Revenue Market Share by Players (2015-2020)
3.1.3 Global Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pharmacovigilance Market Concentration Ratio
3.2.1 Global Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pharmacovigilance Revenue in 2019
3.3 Pharmacovigilance Key Players Head office and Area Served
3.4 Key Players Pharmacovigilance Product Solution and Service
3.5 Date of Enter into Pharmacovigilance Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Pharmacovigilance Historic Market Size by Type (2015-2020)
4.2 Global Pharmacovigilance Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Pharmacovigilance Market Size by Application (2015-2020)
5.2 Global Pharmacovigilance Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Pharmacovigilance Market Size (2015-2020)
6.2 Pharmacovigilance Key Players in North America (2019-2020)
6.3 North America Pharmacovigilance Market Size by Type (2015-2020)
6.4 North America Pharmacovigilance Market Size by Application (2015-2020)

7 Europe
7.1 Europe Pharmacovigilance Market Size (2015-2020)
7.2 Pharmacovigilance Key Players in Europe (2019-2020)
7.3 Europe Pharmacovigilance Market Size by Type (2015-2020)
7.4 Europe Pharmacovigilance Market Size by Application (2015-2020)

8 China
8.1 China Pharmacovigilance Market Size (2015-2020)
8.2 Pharmacovigilance Key Players in China (2019-2020)
8.3 China Pharmacovigilance Market Size by Type (2015-2020)
8.4 China Pharmacovigilance Market Size by Application (2015-2020)

9 Japan
9.1 Japan Pharmacovigilance Market Size (2015-2020)
9.2 Pharmacovigilance Key Players in Japan (2019-2020)
9.3 Japan Pharmacovigilance Market Size by Type (2015-2020)
9.4 Japan Pharmacovigilance Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Pharmacovigilance Market Size (2015-2020)
10.2 Pharmacovigilance Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pharmacovigilance Market Size by Type (2015-2020)
10.4 Southeast Asia Pharmacovigilance Market Size by Application (2015-2020)

11 India
11.1 India Pharmacovigilance Market Size (2015-2020)
11.2 Pharmacovigilance Key Players in India (2019-2020)
11.3 India Pharmacovigilance Market Size by Type (2015-2020)
11.4 India Pharmacovigilance Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Pharmacovigilance Market Size (2015-2020)
12.2 Pharmacovigilance Key Players in Central & South America (2019-2020)
12.3 Central & South America Pharmacovigilance Market Size by Type (2015-2020)
12.4 Central & South America Pharmacovigilance Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Eli Lilly and Company
13.1.1 Eli Lilly and Company Company Details
13.1.2 Eli Lilly and Company Business Overview
13.1.3 Eli Lilly and Company Pharmacovigilance Introduction
13.1.4 Eli Lilly and Company Revenue in Pharmacovigilance Business (2015-2020))
13.1.5 Eli Lilly and Company Recent Development
13.2 ICON plc
13.2.1 ICON plc Company Details
13.2.2 ICON plc Business Overview
13.2.3 ICON plc Pharmacovigilance Introduction
13.2.4 ICON plc Revenue in Pharmacovigilance Business (2015-2020)
13.2.5 ICON plc Recent Development
13.3 Elsevier
13.3.1 Elsevier Company Details
13.3.2 Elsevier Business Overview
13.3.3 Elsevier Pharmacovigilance Introduction
13.3.4 Elsevier Revenue in Pharmacovigilance Business (2015-2020)
13.3.5 Elsevier Recent Development
13.4 Chiltern
13.4.1 Chiltern Company Details
13.4.2 Chiltern Business Overview
13.4.3 Chiltern Pharmacovigilance Introduction
13.4.4 Chiltern Revenue in Pharmacovigilance Business (2015-2020)
13.4.5 Chiltern Recent Development
13.5 Atlantic Research Group
13.5.1 Atlantic Research Group Company Details
13.5.2 Atlantic Research Group Business Overview
13.5.3 Atlantic Research Group Pharmacovigilance Introduction
13.5.4 Atlantic Research Group Revenue in Pharmacovigilance Business (2015-2020)
13.5.5 Atlantic Research Group Recent Development
13.6 Mapi Group
13.6.1 Mapi Group Company Details
13.6.2 Mapi Group Business Overview
13.6.3 Mapi Group Pharmacovigilance Introduction
13.6.4 Mapi Group Revenue in Pharmacovigilance Business (2015-2020)
13.6.5 Mapi Group Recent Development
13.7 Accenture Plc.
13.7.1 Accenture Plc. Company Details
13.7.2 Accenture Plc. Business Overview
13.7.3 Accenture Plc. Pharmacovigilance Introduction
13.7.4 Accenture Plc. Revenue in Pharmacovigilance Business (2015-2020)
13.7.5 Accenture Plc. Recent Development
13.8 Clinquest Group B.V.
13.8.1 Clinquest Group B.V. Company Details
13.8.2 Clinquest Group B.V. Business Overview
13.8.3 Clinquest Group B.V. Pharmacovigilance Introduction
13.8.4 Clinquest Group B.V. Revenue in Pharmacovigilance Business (2015-2020)
13.8.5 Clinquest Group B.V. Recent Development
13.9 GSK
13.9.1 GSK Company Details
13.9.2 GSK Business Overview
13.9.3 GSK Pharmacovigilance Introduction
13.9.4 GSK Revenue in Pharmacovigilance Business (2015-2020)
13.9.5 GSK Recent Development
13.10 PRA Health Sciences, Inc.
13.10.1 PRA Health Sciences, Inc. Company Details
13.10.2 PRA Health Sciences, Inc. Business Overview
13.10.3 PRA Health Sciences, Inc. Pharmacovigilance Introduction
13.10.4 PRA Health Sciences, Inc. Revenue in Pharmacovigilance Business (2015-2020)
13.10.5 PRA Health Sciences, Inc. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Pharmacovigilance Key Market Segments
Table 2. Key Players Covered: Ranking by Pharmacovigilance Revenue
Table 3. Ranking of Global Top Pharmacovigilance Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pharmacovigilance Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Contract Outsourcing
Table 7. Global Pharmacovigilance Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Pharmacovigilance Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Pharmacovigilance Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Pharmacovigilance Market Share by Regions (2015-2020)
Table 11. Global Pharmacovigilance Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Pharmacovigilance Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Pharmacovigilance Market Growth Strategy
Table 17. Main Points Interviewed from Key Pharmacovigilance Players
Table 18. Global Pharmacovigilance Revenue by Players (2015-2020) (Million US$)
Table 19. Global Pharmacovigilance Market Share by Players (2015-2020)
Table 20. Global Top Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance as of 2019)
Table 21. Global Pharmacovigilance by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Pharmacovigilance Product Solution and Service
Table 24. Date of Enter into Pharmacovigilance Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 27. Global Pharmacovigilance Market Size Share by Type (2015-2020)
Table 28. Global Pharmacovigilance Revenue Market Share by Type (2021-2026)
Table 29. Global Pharmacovigilance Market Size Share by Application (2015-2020)
Table 30. Global Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 31. Global Pharmacovigilance Market Size Share by Application (2021-2026)
Table 32. North America Key Players Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Pharmacovigilance Market Share (2019-2020)
Table 34. North America Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 35. North America Pharmacovigilance Market Share by Type (2015-2020)
Table 36. North America Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 37. North America Pharmacovigilance Market Share by Application (2015-2020)
Table 38. Europe Key Players Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Pharmacovigilance Market Share (2019-2020)
Table 40. Europe Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Pharmacovigilance Market Share by Type (2015-2020)
Table 42. Europe Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Pharmacovigilance Market Share by Application (2015-2020)
Table 44. China Key Players Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 45. China Key Players Pharmacovigilance Market Share (2019-2020)
Table 46. China Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 47. China Pharmacovigilance Market Share by Type (2015-2020)
Table 48. China Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 49. China Pharmacovigilance Market Share by Application (2015-2020)
Table 50. Japan Key Players Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Pharmacovigilance Market Share (2019-2020)
Table 52. Japan Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Pharmacovigilance Market Share by Type (2015-2020)
Table 54. Japan Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Pharmacovigilance Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Pharmacovigilance Market Share (2019-2020)
Table 58. Southeast Asia Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Pharmacovigilance Market Share by Type (2015-2020)
Table 60. Southeast Asia Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Pharmacovigilance Market Share by Application (2015-2020)
Table 62. India Key Players Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 63. India Key Players Pharmacovigilance Market Share (2019-2020)
Table 64. India Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 65. India Pharmacovigilance Market Share by Type (2015-2020)
Table 66. India Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 67. India Pharmacovigilance Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Pharmacovigilance Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Pharmacovigilance Market Share (2019-2020)
Table 70. Central & South America Pharmacovigilance Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Pharmacovigilance Market Share by Type (2015-2020)
Table 72. Central & South America Pharmacovigilance Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Pharmacovigilance Market Share by Application (2015-2020)
Table 74. Eli Lilly and Company Company Details
Table 75. Eli Lilly and Company Business Overview
Table 76. Eli Lilly and Company Product
Table 77. Eli Lilly and Company Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 78. Eli Lilly and Company Recent Development
Table 79. ICON plc Company Details
Table 80. ICON plc Business Overview
Table 81. ICON plc Product
Table 82. ICON plc Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 83. ICON plc Recent Development
Table 84. Elsevier Company Details
Table 85. Elsevier Business Overview
Table 86. Elsevier Product
Table 87. Elsevier Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 88. Elsevier Recent Development
Table 89. Chiltern Company Details
Table 90. Chiltern Business Overview
Table 91. Chiltern Product
Table 92. Chiltern Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 93. Chiltern Recent Development
Table 94. Atlantic Research Group Company Details
Table 95. Atlantic Research Group Business Overview
Table 96. Atlantic Research Group Product
Table 97. Atlantic Research Group Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 98. Atlantic Research Group Recent Development
Table 99. Mapi Group Company Details
Table 100. Mapi Group Business Overview
Table 101. Mapi Group Product
Table 102. Mapi Group Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 103. Mapi Group Recent Development
Table 104. Accenture Plc. Company Details
Table 105. Accenture Plc. Business Overview
Table 106. Accenture Plc. Product
Table 107. Accenture Plc. Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 108. Accenture Plc. Recent Development
Table 109. Clinquest Group B.V. Business Overview
Table 110. Clinquest Group B.V. Product
Table 111. Clinquest Group B.V. Company Details
Table 112. Clinquest Group B.V. Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 113. Clinquest Group B.V. Recent Development
Table 114. GSK Company Details
Table 115. GSK Business Overview
Table 116. GSK Product
Table 117. GSK Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 118. GSK Recent Development
Table 119. PRA Health Sciences, Inc. Company Details
Table 120. PRA Health Sciences, Inc. Business Overview
Table 121. PRA Health Sciences, Inc. Product
Table 122. PRA Health Sciences, Inc. Revenue in Pharmacovigilance Business (2015-2020) (Million US$)
Table 123. PRA Health Sciences, Inc. Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacovigilance Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Contract Outsourcing Features
Figure 4. Global Pharmacovigilance Market Share by Application: 2020 VS 2026
Figure 5. Pharma and Biotech Companies Case Studies
Figure 6. Contract Research Organizations (CROs) Case Studies
Figure 7. Business Process Outsourcing (BPO) Firms Case Studies
Figure 8. Other Pharmacovigilance Service Providers Case Studies
Figure 9. Pharmacovigilance Report Years Considered
Figure 10. Global Pharmacovigilance Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Pharmacovigilance Market Share by Regions: 2020 VS 2026
Figure 12. Global Pharmacovigilance Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Pharmacovigilance Market Share by Players in 2019
Figure 15. Global Top Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacovigilance as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Pharmacovigilance Revenue in 2019
Figure 17. North America Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Pharmacovigilance Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のファーマコビジランス市場2026:インサイト・予測] (Global Pharmacovigilance Market Size, Status and Forecast 2020-2026 / QYR20NV04258)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆